Previous 10 | Next 10 |
2024-05-04 16:47:00 ET The healthcare sector had 24 companies reporting their quarterly earnings this week, with 16 of them beating their topline numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 16 out of 24 health care companies be...
2024-05-03 12:53:06 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions Pfizer raises guidance ...
2024-05-03 09:31:56 ET Summary BioNTech is a biotech company with a strong cash position and a commercial program generating cash flow, making it a promising investment opportunity. The company's pipeline includes programs targeting cancer, respiratory infections, and other diseas...
2024-05-03 09:25:51 ET Summary BioNTech is expected to report a significant decline in sales for the first quarter, mainly due to the decline in COVID vaccine revenues. The company's earnings per share is also expected to be worse compared to the previous year. Investors shoul...
2024-05-01 10:27:47 ET Summary Genmab's stock has lost over 35% of its value since December 2022 due to unfavorable arbitration cases and high spending on launching Epkinly. The company's top line is currently dominated by royalties from Darzalex, but it hopes Epkinly will contrib...
2024-05-01 08:37:31 ET More on Pfizer Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer beats top-line and bottom-line estima...
2024-04-27 14:11:33 ET More on Pfizer Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk Pfizer gets FDA approval fo...
2024-04-25 10:56:02 ET More on GSK GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript) GSK Plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy Sanofi reporte...
2024-04-24 11:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund increased 1.68% in the first quarter. The Fund underperf...
2024-04-22 14:20:23 ET Summary Hookipa Pharma is conducting a call on 04/25/24 to share lead asset HB-200's pivotal trial design. A Phase 2a clinical update is due in 2Q'24. The company's shares closed at $0.733, with a valuation of approximately $72.53. Positive data ...
News, Short Squeeze, Breakout and More Instantly...
BioNTech SE Company Name:
BNTX Stock Symbol:
NYSE Market:
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with&n...
MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the vir...
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech...